In addition to our clinical study, the TCGA results also demonstrated significant differences in EFTUD2 expression across the subgroups of pathologic N stage (N1 vs. N0), cancer stage (III vs. I), and smoking history (current smoker vs. previous smoker; Figure 1G). The gene discussed is EFTUD2; the disease is cancer.